Evolution of Cardiac Damage in MitraClip

Degenerative mitral valve regurgitation affects the mitral apparatus and is related to severe insufficiency. At present, surgery is the treatment of choice for patients at low risk. 

La reparación de la válvula mitral con Mitraclip es segura en pacientes de alto riesgo

Oftentimes, this disease affects the elderly and/or those at high surgical risk, edge-to-edge repair being an excellent treatment alternative. 

We all know that the different stages of ventricular function deterioration have a negative impact on disease evolution, but there is little information on the impact of edge-to-edge evolution on each of these stages.

This analysis looked at 579 patients undergoing edge-to-edge repair with MitraClip to treat degenerative mitral valve regurgitation, classified according to cardiac damage. 

Stage 0 (S0) patients showed no cardiac damage. Stage 1 (S1) showed damage to the medial portion of the left ventricle or the left atrial (defined by ejection fraction ≤60%, end diastolic diameter >55 mm, end systolic diameter >35 mm, left atrial indexed volume ≥40 ml/m2 or atrial fibrillation). Stage 2 (S2) patients showed moderate damage to the left ventricle or the left atrial (defined by left ventricular ejection fraction ≤50%, end diastolic diameter >60 mm, end systolic diameter >40 mm, left atrial indexed volume ≥60 ml/m2). And stage 3 (S3), showed right heart damage (defined as right tricuspid regurgitation or severe right ventricular function deterioration).

Read also: Prehospital Crushed vs. Integral Prasugrel in STEMI Patients with Large Myocardial Area at Risk

Patients in S0 or S1 were 84, S2 319 patients and S3 176 patients.

Mean age was 82 and 52% were women. Compared against patients in S0 or S1, patients in the more advanced stages presented more comorbidities, more hospitalization for cardiac failure and higher BNP levels.

By the end of procedure, S0 and S1 patients had residual mitral valve regurgitation ≤1+.

At 2 years, survival resulted higher in S0 and S1 patients vs. the other two stages (100% vs. 89.5% vs. 78.9% vs. 75.3%, respectively, p=0.013). All stages showed a reduction in hospitalization for cardiac failure vs. the prior year, but this reduction was higher for S= and S1 patients. 

Read also: Predictors of DCB Failure in De Novo Lesions.

There was an improvement in functional class in all groups, but the presence of functional class III-IV was more frequent in the more advanced stages. 

There was a reduction in mitral regurgitation maintained over time in all patients. 

After multivariable analysis, mortality predictors at 2 years were S2 and S3, female sex, functional class III-IV and residual mitral valve regurgitation >2+.

Conclusion

Advanced damage was associated with increased mortality risk in patients undergoing edge-to-edge repair for degenerative mitral valve regurgitation. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Cardiac Damage in Degenerative Mitral Regurgitation Treated With Transcatheter Mitral Edge-to-Edge Repair.

Reference: Atsushi Sugiura, et al. Circ Cardiovasc Interv. 2024;17:e013794. DOI: 10.1161/CIRCINTERVENTIONS.123.013794.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...